Novo Nordisk shares are rising. The FDA approves another use for Wegovy.By Mario Cazombo / August 18, 2025 The FDA approved Wegovy for use in a form of liver disease.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General